CN109864930A - 一种具有抗炎止痒功效的植物提取物组合物及其制备方法、应用 - Google Patents
一种具有抗炎止痒功效的植物提取物组合物及其制备方法、应用 Download PDFInfo
- Publication number
- CN109864930A CN109864930A CN201811630734.2A CN201811630734A CN109864930A CN 109864930 A CN109864930 A CN 109864930A CN 201811630734 A CN201811630734 A CN 201811630734A CN 109864930 A CN109864930 A CN 109864930A
- Authority
- CN
- China
- Prior art keywords
- inflammation
- composition
- stopping
- plant extracts
- resisting itch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 41
- 239000000419 plant extract Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 230000000694 effects Effects 0.000 claims abstract description 45
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 19
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 241000246500 Gentianella aspera Species 0.000 claims abstract description 17
- 244000302909 Piper aduncum Species 0.000 claims abstract description 17
- 235000016761 Piper aduncum Nutrition 0.000 claims abstract description 17
- 239000002537 cosmetic Substances 0.000 claims abstract description 6
- 239000003480 eluent Substances 0.000 claims description 48
- 239000006228 supernatant Substances 0.000 claims description 36
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 27
- 235000002906 tartaric acid Nutrition 0.000 claims description 27
- 239000011975 tartaric acid Substances 0.000 claims description 27
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 22
- 238000010828 elution Methods 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000469 ethanolic extract Substances 0.000 claims description 15
- 239000011347 resin Substances 0.000 claims description 14
- 229920005989 resin Polymers 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 235000019441 ethanol Nutrition 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- AXPZIVKEZRHGAS-UHFFFAOYSA-N 3-benzyl-5-[(2-nitrophenoxy)methyl]oxolan-2-one Chemical compound [O-][N+](=O)C1=CC=CC=C1OCC1OC(=O)C(CC=2C=CC=CC=2)C1 AXPZIVKEZRHGAS-UHFFFAOYSA-N 0.000 claims description 7
- 238000010583 slow cooling Methods 0.000 claims description 7
- 239000004952 Polyamide Substances 0.000 claims description 6
- 239000002250 absorbent Substances 0.000 claims description 6
- 230000002745 absorbent Effects 0.000 claims description 6
- 229920002647 polyamide Polymers 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims 1
- 239000004575 stone Substances 0.000 claims 1
- 210000004761 scalp Anatomy 0.000 abstract description 33
- 241000196324 Embryophyta Species 0.000 abstract description 15
- 230000006378 damage Effects 0.000 abstract description 9
- 230000004888 barrier function Effects 0.000 abstract description 5
- 230000008439 repair process Effects 0.000 abstract description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 24
- 238000000605 extraction Methods 0.000 description 17
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000555688 Malassezia furfur Species 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000002077 nanosphere Substances 0.000 description 5
- 229920006122 polyamide resin Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- -1 half-day type Natural products 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 229930182489 iridoid glycoside Natural products 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 150000004985 diamines Chemical class 0.000 description 3
- 150000004141 diterpene derivatives Chemical class 0.000 description 3
- 150000008145 iridoid glycosides Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000010282 Emodin Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241001289529 Fallopia multiflora Species 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 244000292697 Polygonum aviculare Species 0.000 description 2
- 235000006386 Polygonum aviculare Nutrition 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 230000003035 anti-peroxidant effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 229930004069 diterpene Natural products 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 229930003935 flavonoid Chemical class 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000004770 highest occupied molecular orbital Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 238000006068 polycondensation reaction Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- OTEKOJQFKOIXMU-UHFFFAOYSA-N 1,4-bis(trichloromethyl)benzene Chemical compound ClC(Cl)(Cl)C1=CC=C(C(Cl)(Cl)Cl)C=C1 OTEKOJQFKOIXMU-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ZMYIIHDQURVDRB-UHFFFAOYSA-N 1-phenylethenylbenzene Chemical group C=1C=CC=CC=1C(=C)C1=CC=CC=C1 ZMYIIHDQURVDRB-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241001135871 Gentiana scabra Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- ZUKLFFYDSALIQW-MSUKCBDUSA-N Iridoid glycoside Chemical compound [H][C@]12CC[C@H](C(O)=O)[C@@]1([H])[C@H](OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC=C2 ZUKLFFYDSALIQW-MSUKCBDUSA-N 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 241001643642 Viticis Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- RGHILYZRVFRRNK-UHFFFAOYSA-N anthracene-1,2-dione Chemical class C1=CC=C2C=C(C(C(=O)C=C3)=O)C3=CC2=C1 RGHILYZRVFRRNK-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 238000013043 cell viability test Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940075285 dandruff control Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- DFNZYFAJQPLJFI-UHFFFAOYSA-N gentianine Chemical compound O=C1OCCC2=C1C=NC=C2C=C DFNZYFAJQPLJFI-UHFFFAOYSA-N 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- XQXJJLJZFOECNK-UHFFFAOYSA-N halimane Chemical compound C1CCC(C)(C)C2C1C(CCC(C)CC)(C)C(C)CC2 XQXJJLJZFOECNK-UHFFFAOYSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000012994 industrial processing Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229920005610 lignin Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 190000012306 pyrithione zinc Chemical compound 0.000 description 1
- 229960001141 pyrithione zinc Drugs 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
仪器试剂名称 | 品牌 | 型号 |
ABTS检测试剂盒 | 碧云天生物 | S0119-300次 |
VC | 国药 | 10004014-25G |
96孔板 | Corning | 3599 |
酶标仪 | Thermo | MultiSkan FC |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811630734.2A CN109864930B (zh) | 2018-12-29 | 2018-12-29 | 一种具有头皮护理功效的植物提取物组合物及其制备方法、应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811630734.2A CN109864930B (zh) | 2018-12-29 | 2018-12-29 | 一种具有头皮护理功效的植物提取物组合物及其制备方法、应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109864930A true CN109864930A (zh) | 2019-06-11 |
CN109864930B CN109864930B (zh) | 2021-12-28 |
Family
ID=66917381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811630734.2A Active CN109864930B (zh) | 2018-12-29 | 2018-12-29 | 一种具有头皮护理功效的植物提取物组合物及其制备方法、应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109864930B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110522665A (zh) * | 2019-09-17 | 2019-12-03 | 上海珈凯生物科技有限公司 | 一种头皮护理组合物及其制备和在头皮护理产品中的应用 |
CN110693776A (zh) * | 2019-10-23 | 2020-01-17 | 广州妮趣化妆品有限公司 | 一种去屑止痒的头皮精华及其制备方法 |
CN111973688A (zh) * | 2020-08-31 | 2020-11-24 | 上海珈凯生物科技有限公司 | 具有缓解头皮炎症、止痒功效的中药组合物及其制备方法 |
CN112294673A (zh) * | 2020-09-30 | 2021-02-02 | 华仁健康产业(青岛)有限公司 | 一种美白面膜及其制备方法 |
CN112494376A (zh) * | 2019-09-16 | 2021-03-16 | 上海和黄白猫有限公司 | 一种汉方洗发水及其制备方法 |
CN112569287A (zh) * | 2019-09-28 | 2021-03-30 | 广州市中通生化制品有限公司 | 一种抗敏止痒植物组合物及其制备方法与应用 |
CN113842342A (zh) * | 2021-09-14 | 2021-12-28 | 广州锦同生物科技有限公司 | 一种植物去屑止痒剂及其制备方法和应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009079018A (ja) * | 2007-09-27 | 2009-04-16 | Kao Corp | 頭皮用化粧料 |
CN103767930A (zh) * | 2012-10-23 | 2014-05-07 | 王伟楠 | 一种中药龙首三营养香波 |
CN104586671A (zh) * | 2013-11-03 | 2015-05-06 | 郑方 | 一种中药何首乌叶面膜 |
CN104586672A (zh) * | 2013-11-03 | 2015-05-06 | 郑方 | 一种中药何首乌叶保健浴盐 |
CN107737048A (zh) * | 2017-11-28 | 2018-02-27 | 广西协成日用化工有限公司 | 一种止痒洗发液及其制备方法 |
CN108014202A (zh) * | 2016-11-01 | 2018-05-11 | 上海珈凯生物科技有限公司 | 一种具有抗皮肤刺激功效的中药提取物组合物及其制备方法 |
FR3059898A1 (fr) * | 2016-12-12 | 2018-06-15 | Oreal | Procede de coloration capillaire mettant en œuvre un sel de titane et un ou plusieurs derives d’ortho-dihydroxy-1,2-diphenylethylene |
CN108721179A (zh) * | 2017-04-25 | 2018-11-02 | 上海珈凯生物科技有限公司 | 一种具有美白功效的植物提取物组合物及制法和用途 |
-
2018
- 2018-12-29 CN CN201811630734.2A patent/CN109864930B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009079018A (ja) * | 2007-09-27 | 2009-04-16 | Kao Corp | 頭皮用化粧料 |
CN103767930A (zh) * | 2012-10-23 | 2014-05-07 | 王伟楠 | 一种中药龙首三营养香波 |
CN104586671A (zh) * | 2013-11-03 | 2015-05-06 | 郑方 | 一种中药何首乌叶面膜 |
CN104586672A (zh) * | 2013-11-03 | 2015-05-06 | 郑方 | 一种中药何首乌叶保健浴盐 |
CN108014202A (zh) * | 2016-11-01 | 2018-05-11 | 上海珈凯生物科技有限公司 | 一种具有抗皮肤刺激功效的中药提取物组合物及其制备方法 |
FR3059898A1 (fr) * | 2016-12-12 | 2018-06-15 | Oreal | Procede de coloration capillaire mettant en œuvre un sel de titane et un ou plusieurs derives d’ortho-dihydroxy-1,2-diphenylethylene |
CN108721179A (zh) * | 2017-04-25 | 2018-11-02 | 上海珈凯生物科技有限公司 | 一种具有美白功效的植物提取物组合物及制法和用途 |
CN107737048A (zh) * | 2017-11-28 | 2018-02-27 | 广西协成日用化工有限公司 | 一种止痒洗发液及其制备方法 |
Non-Patent Citations (2)
Title |
---|
王宗玉等: "《中国原料植物学》", 28 February 2002, 云南科学技术出版社 * |
董广民: "《《本草纲目》中药养生速查全书》", 31 May 2015, 中医古籍出版社 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112494376A (zh) * | 2019-09-16 | 2021-03-16 | 上海和黄白猫有限公司 | 一种汉方洗发水及其制备方法 |
CN110522665A (zh) * | 2019-09-17 | 2019-12-03 | 上海珈凯生物科技有限公司 | 一种头皮护理组合物及其制备和在头皮护理产品中的应用 |
CN112569287A (zh) * | 2019-09-28 | 2021-03-30 | 广州市中通生化制品有限公司 | 一种抗敏止痒植物组合物及其制备方法与应用 |
CN112569287B (zh) * | 2019-09-28 | 2021-12-21 | 广州市中通生化制品有限公司 | 一种抗敏止痒植物组合物及其制备方法与应用 |
CN110693776A (zh) * | 2019-10-23 | 2020-01-17 | 广州妮趣化妆品有限公司 | 一种去屑止痒的头皮精华及其制备方法 |
CN111973688A (zh) * | 2020-08-31 | 2020-11-24 | 上海珈凯生物科技有限公司 | 具有缓解头皮炎症、止痒功效的中药组合物及其制备方法 |
CN112294673A (zh) * | 2020-09-30 | 2021-02-02 | 华仁健康产业(青岛)有限公司 | 一种美白面膜及其制备方法 |
CN113842342A (zh) * | 2021-09-14 | 2021-12-28 | 广州锦同生物科技有限公司 | 一种植物去屑止痒剂及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN109864930B (zh) | 2021-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109864930A (zh) | 一种具有抗炎止痒功效的植物提取物组合物及其制备方法、应用 | |
KR102147833B1 (ko) | 펩타이드를 함유하는 피부 개선용 화장료 조성물 | |
CN108403495A (zh) | 一种山茶花提取物及包含该山茶花提取物的中草药化妆品 | |
WO2004078155A1 (fr) | Utilisation d'un extrait total de flavonoide d'une feuille de bambou dans des compositions cosmetiques comme facteur anti-vieillissement | |
CN103385837B (zh) | 一种杨梅叶原花色素化妆水及其制备方法 | |
CN101347396A (zh) | 含有植物提取物的洗面乳 | |
KR20120009554A (ko) | 항산화 및 항알레르기 효과를 갖는 허브 추출물 함유하는 화장료 조성물 | |
KR100544024B1 (ko) | 피부 미백용 조성물 | |
CN106468016B (zh) | 一种含桃叶提取物的祛痱止痒驱蚊棉织物及其制备方法 | |
CN108524336A (zh) | 一种八角金盘天然活性护肤霜及其制备方法 | |
CN110613663A (zh) | 一种皮肤修护组合物、护肤品及其制备方法 | |
CH675355A5 (zh) | ||
CN108498380A (zh) | 一种啤酒花面膜及其制备方法 | |
KR100789632B1 (ko) | 멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는피부미백용 화장료 | |
KR100466379B1 (ko) | 피부미백용 조성물 | |
KR100789634B1 (ko) | 멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는피부미백용 화장료 | |
CN105310918A (zh) | 一种绿萝花提取物及其应用 | |
KR101757457B1 (ko) | 천연 복합 추출물을 함유하는 열노화 방지 및 피부 진정용 화장료 조성물 | |
KR20050092313A (ko) | 멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는피부미백용 화장료 | |
CN106619308A (zh) | 一种美白滋润组合物 | |
KR100670530B1 (ko) | 철현채 추출물, 유엽 추출물에서 선택되는 1종 이상을유효성분으로 함유하는 화장료 조성물 | |
JPH11147833A (ja) | コラゲナーゼ阻害剤 | |
KR20050092314A (ko) | 멜라닌 생성 억제 활성을 갖는 식물 추출물을 함유하는피부미백용 화장료 | |
CN102949444A (zh) | 丹参多酚酸有效部位在制备改善皮肤肤质制剂中的应用 | |
KR20150116301A (ko) | 피지 억제 및 피부자극 완화 효과를 갖는 유카, 보골지 및 비단풀 혼합추출물을 유효성분으로 함유하는 클렌징 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 201203 building 6, No. 857, Tiangong Road, Jinshan Industrial Zone, Shanghai Patentee after: Shanghai Jiakai Biological Co.,Ltd. Address before: 201203 building 6, No. 857, Tiangong Road, Jinshan Industrial Zone, Shanghai Patentee before: SHANGHAI JIAKAI BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: No. 818 Tiangong Road, Jinshan District, Shanghai, 200540 Patentee after: Shanghai Jiakai Biological Co.,Ltd. Address before: 201203 building 6, No. 857, Tiangong Road, Jinshan Industrial Zone, Shanghai Patentee before: Shanghai Jiakai Biological Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |